タイプによる市場セグメンテーションは以下をカバーします：
S. haematobium
オキサムニキン
他人 アプリケーションによる市場細分化：
S. haematobium
マンソン住血吸虫
S.ジャポニカ
S. mekongi
S. intercalatum
ドライバー、拘束、および機会とは別に、レポートはまた、業界で重要な位置を確立するためにプロファイルされたプレーヤーによって採用されたさまざまな成長戦略を含む、競争力のある風景を提供します。 包括的なレポートに含まれるセグメンテーションは、立派なメーカーが地域に処理ユニットを設置し、グローバルな存在感を高めるのに役立ちます。 これは業界にも利益をもたらし、会社の製品ポートフォリオを増やします。
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL DRUGS FOR SCHISTOSOMIASIS INDUSTRY
2.1 Summary about Drugs for Schistosomiasis Industry
2.2 Drugs for Schistosomiasis Market Trends
2.2.1 Drugs for Schistosomiasis Production & Consumption Trends
2.2.2 Drugs for Schistosomiasis Demand Structure Trends
2.3 Drugs for Schistosomiasis Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Praziquantel
4.2.2 Oxamniquine
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 S. haematobium
4.3.2 S. mansoni
4.3.3 S. japonicum
4.3.4 S. mekongi
4.3.5 S. intercalatum
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Praziquantel
5.2.2 Oxamniquine
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 S. haematobium
5.3.2 S. mansoni
5.3.3 S. japonicum
5.3.4 S. mekongi
5.3.5 S. intercalatum
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Praziquantel
6.2.2 Oxamniquine
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 S. haematobium
6.3.2 S. mansoni
6.3.3 S. japonicum
6.3.4 S. mekongi
6.3.5 S. intercalatum
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Praziquantel
7.2.2 Oxamniquine
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 S. haematobium
7.3.2 S. mansoni
7.3.3 S. japonicum
7.3.4 S. mekongi
7.3.5 S. intercalatum
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Praziquantel
8.2.2 Oxamniquine
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 S. haematobium
8.3.2 S. mansoni
8.3.3 S. japonicum
8.3.4 S. mekongi
8.3.5 S. intercalatum
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Praziquantel
9.2.2 Oxamniquine
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 S. haematobium
9.3.2 S. mansoni
9.3.3 S. japonicum
9.3.4 S. mekongi
9.3.5 S. intercalatum
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Merck
10.1.2 Shin Poong
10.1.3 Bayer
10.1.4 EIPICO
10.1.5 Chandra Bhagat Pharma
10.1.6 Taj Pharmaceuticals
10.2 Drugs for Schistosomiasis Sales Date of Major Players (2017-2020e)
10.2.1 Merck
10.2.2 Shin Poong
10.2.3 Bayer
10.2.4 EIPICO
10.2.5 Chandra Bhagat Pharma
10.2.6 Taj Pharmaceuticals
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
